Search

Your search keyword '"Schoemaker M.J."' showing total 47 results

Search Constraints

Start Over You searched for: Author "Schoemaker M.J." Remove constraint Author: "Schoemaker M.J."
47 results on '"Schoemaker M.J."'

Search Results

1. 76P Immune checkpoint inhibitor (ICI) retreatment patterns and outcomes in patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) who received second-line or later (2L+) nivolumab (nivo): A French I-O optimise analysis

2. EPH82 Real-World Outcomes in Patients with Resected Non-Small Cell Lung Cancer (NSCLC) Receiving (NEO)Adjuvant Treatment in Germany: An I-O Optimise Analysis

3. P1.25-05 Real-World Outcomes in Non-metastatic Non-small Cell Lung Cancer (NSCLC): An I-O Optimise Multi-Country Analysis

4. EP08.02-04 Real-World Disease-Free Survival (DFS) in Non-metastatic Non-small Cell Lung Cancer (NSCLC): A German I-O Optimise Analysis

6. Functional annotation of the 2q35 breast cancer risk locus implicates a structural variant in influencing activity of a long-range enhancer element

7. Mendelian randomisation study of smoking exposure in relation to breast cancer risk.

8. Genetic insights into biological mechanisms governing human ovarian ageing.

9. Functional annotation of the 2q35 breast cancer risk locus implicates a structural variant in influencing activity of a long-range enhancer element.

10. CYP3A7*1C allele: linking premenopausal oestrone and progesterone levels with risk of hormone receptor-positive breast cancers.

11. Combined Associations of a Polygenic Risk Score and Classical Risk Factors with Breast Cancer Risk.

12. Germline variants and breast cancer survival in patients with distant metastases at primary breast cancer diagnosis.

13. Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses

14. Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes

15. Two truncating variants in FANCC and breast cancer risk.

16. Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes.

17. Transcriptome-wide association study of breast cancer risk by estrogen-receptor status.

18. Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses.

19. Transcriptome-wide association study of breast cancer risk by estrogen-receptor status

20. Two truncating variants in FANCC and breast cancer risk

21. Genome-wide association study of germline variants and breast cancer-specific mortality

22. Epigenome-wide association study for lifetime estrogen exposure identifies an epigenetic signature associated with breast cancer risk.

23. Genome-wide association study of germline variants and breast cancer-specific mortality.

24. Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes.

25. Etiology of hormone receptor positive breast cancer differs by levels of histologic grade and proliferation

26. The BRCA2 c.68-7T > A variant is not pathogenic: A model for clinical calibration of spliceogenicity

27. Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation (vol 5, 4999, 2014)

28. The BRCA2 c.68-7T > A variant is not pathogenic: A model for clinical calibration of spliceogenicity

29. Etiology of hormone receptor positive breast cancer differs by levels of histologic grade and proliferation

30. E-cadherin breast tumor expression, risk factors and survival: Pooled analysis of 5,933 cases from 12 studies in the Breast Cancer Association Consortium

31. Gene-environment interactions involving functional variants

32. Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer

33. Genetic modifiers of CHEK2∗1100delC-associated breast cancer risk

34. Evidence that the 5p12 Variant rs10941679 Confers Susceptibility to Estrogen-Receptor-Positive Breast Cancer through FGF10 and MRPS30 Regulation

35. Evidence that the 5p12 variant rs10941679 confers susceptibility to estrogen receptor positive breast cancer through FGF10 and MRPS30 regulation

36. Genetic predisposition to ductal carcinoma in situ of the breast

37. BRCA2 polymorphic stop codon K3326X and the risk of breast, prostate, and ovarian cancers

38. Prediction of Breast Cancer Risk Based on Profiling With Common Genetic Variants

39. Fine-mapping identifies two additional breast cancer susceptibility loci at 9q31.2

40. Identification of independent association signals and putative functional variants for breast cancer risk through fine-scale mapping of the 12p11 locus

41. Genetic variation at CYP3A is associated with age at menarche and breast cancer risk: a case-control study

42. 19p13.1 Is a triple-negative-specific breast cancer susceptibility locus

43. Navigation in multimedia environments

44. Navigatie op multimediasystemen

Catalog

Books, media, physical & digital resources